10: NCI Salvage Low Dose Rate Prostate Brachytherapy: Clinical Outcomes of a Phase II Trial...

Prostate-specific membrane antigen targeted PET/CT for recurrent prostate cancer: a clinician's guide

S Young, W Liu, K Zukotynski… - Expert Review of …, 2021 - Taylor & Francis
ABSTRACT Introduction PSMA-targeted PET/CT is a 'Next Generation Imaging'technique
with superior sensitivity and specificity for detecting recurrent prostate cancer compared with …
被引用次数：10 相关文章 所有 4 个版本